Paper40205346
Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon.
Gouveia MIM and 12 others. BMC Microbiol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon. Papers, record 40205346. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40205346
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Pseudomonas Infections | Major topic |
| Humans | |
| Brazil | |
| Male | |
| Female | |
| Cross-Sectional Studies | |
| Adult | |
| Molecular Epidemiology | |
| Young Adult | |
| Adolescent | |
| Multilocus Sequence Typing | |
| Virulence Factors | |
| Anti-Bacterial Agents | |
| Child | |
| Microbial Sensitivity Tests | |
| Genetic Variation | |
| Genotype | |
| Drug Resistance, Multiple, Bacterial | |
| Middle Aged | |
| Child, Preschool |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Edital 16/2022-File Nº 88887.759036/2022-00 | PDPG-Pós-Doutorado Estratégico (PDPG-POSDOC), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | PubMed |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35752612 | Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35752612 | PubMed |
| 2 | 24836205 | Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. | Lancet Respir Med | 2014 | https://conductscience.org/library/papers/24836205 | PubMed |
| 3 | 38160753 | Pseudomonasaeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group. | Clin Microbiol Infect | 2024 | https://conductscience.org/library/papers/38160753 | PubMed |
| 4 | 21793988 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. | Clin Microbiol Infect | 2012 | https://conductscience.org/library/papers/21793988 | PubMed |
| 5 | 38088541 | The type III secretion system facilitates systemic infections of Pseudomonas aeruginosa in the clinic. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38088541 | PubMed |
| 6 | 31142499 | Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface. | Clin Microbiol Rev | 2019 | https://conductscience.org/library/papers/31142499 | PubMed |
| 7 | 38867891 | Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacterales in Fiji: a multicentre prospective observational study. | Lancet Reg Health West Pac | 2024 | https://conductscience.org/library/papers/38867891 | PubMed |
| 8 | 31350412 | High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals. | Sci Rep | 2019 | https://conductscience.org/library/papers/31350412 | PubMed |
| 9 | 33214718 | Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. | Nat Rev Microbiol | 2021 | https://conductscience.org/library/papers/33214718 | PubMed |
| 10 | 35240288 | Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: A systematic review and meta-analysis. | Microb Pathog | 2022 | https://conductscience.org/library/papers/35240288 | PubMed |
| 11 | 24982833 | Correlation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa. | Ann Lab Med | 2014 | https://conductscience.org/library/papers/24982833 | PubMed |
| 12 | 28923877 | Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28923877 | PubMed |
| 13 | 37268599 | Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37268599 | PubMed |
| 14 | 31767719 | Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/31767719 | PubMed |
| 15 | 33673029 | Diversity and Distribution of Resistance Markers in Pseudomonas aeruginosa International High-Risk Clones. | Microorganisms | 2021 | https://conductscience.org/library/papers/33673029 | PubMed |
| 16 | 39338911 | Genomic Insights into Vietnamese Extended-Spectrum β-Lactamase-9-Producing Extensively Drug-Resistant Pseudomonas aeruginosa Isolates Belonging to the High-Risk Clone ST357 Obtained from Bulgarian Intensive Care Unit Patients. | Pathogens | 2024 | https://conductscience.org/library/papers/39338911 | PubMed |
| 17 | 33092201 | Relationship between Virulence and Resistance among Gram-Negative Bacteria. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/33092201 | PubMed |
| 18 | 37764210 | The Prevalence of Metallo-Beta-Lactamese-(MβL)-Producing Pseudomonas aeruginosa Isolates in Brazil: A Systematic Review and Meta-Analysis. | Microorganisms | 2023 | https://conductscience.org/library/papers/37764210 | PubMed |
| 19 | 28735882 | Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study. | Int J Antimicrob Agents | 2017 | https://conductscience.org/library/papers/28735882 | PubMed |
| 20 | 37998763 | Spread of Pseudomonas aeruginosa ST274 Clone in Different Niches: Resistome, Virulome, and Phylogenetic Relationship. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37998763 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40205346
GET https://conductscience.org/api/papers/v1/40205346/references?page=2